Impact of PHiD-CV10 on all-cause Acute Otitis Media (AOM) in children under three years of age in Iceland.

Trial Profile

Impact of PHiD-CV10 on all-cause Acute Otitis Media (AOM) in children under three years of age in Iceland.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2018

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
  • Indications Otitis media
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Apr 2018 New trial record
    • 30 Mar 2018 Results published in the Clinical Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top